Skip to content
10-K

Annual Report

PROLOR BIOTECH, INC.

0001144204-13-015454

← back to feed
Filed
Mar 15, 2013 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2012 · Mar 1, 2013 63.43M sh
Capex FY 2012 · Dec 31, 2012 $484.2K
Capex FY 2012 · Dec 31, 2012 $1.75M
Operating Cash Flow FY 2012 · Dec 31, 2012 −$16.39M
Operating Cash Flow FY 2012 · Dec 31, 2012 −$50.39M
Cash And Equivalents FY 2012 · Dec 31, 2012 $23.85M
Cash And Equivalents FY 2012 · May 30, 2005 $0
Stockholders Equity FY 2012 · Dec 31, 2012 $33.2M
Stockholders Equity FY 2012 · May 30, 2005 $0
Current Liabilities FY 2012 · Dec 31, 2012 $2.34M
Current Assets FY 2012 · Dec 31, 2012 $34.44M
Total Assets FY 2012 · Dec 31, 2012 $35.92M
Sga Expense FY 2012 · Dec 31, 2012 $3.36M
Sga Expense FY 2012 · Dec 31, 2012 $20.11M
Rd Expense FY 2012 · Dec 31, 2012 $15.03M
Rd Expense FY 2012 · Dec 31, 2012 $48.35M
Rd Expense FY 2012 · Dec 31, 2011 $11.62M
Rd Expense FY 2012 · Dec 31, 2010 $5.31M
Net Income FY 2012 · Dec 31, 2012 −$18.27M
Net Income FY 2012 · Dec 31, 2012 −$67.92M
Operating Income FY 2012 · Dec 31, 2012 −$18.39M
Operating Income FY 2012 · Dec 31, 2012 −$68.46M
Revenue FY 2012 · Dec 31, 2012 $0
Revenue FY 2012 · Dec 31, 2012 $0
Revenue FY 2012 · Dec 31, 2011 $0
Revenue FY 2012 · Dec 31, 2010 $0